Amgen’s Lumakras and AstraZeneca’s Calquence are both in line to expand their respective oncology reaches with new FDA ...

Biopharma executives make their predictions for the year ahead, from a bold forecast for the return of the megadeal to a plea ...

GE HealthCare Technologies, Inc. GEHC is well-poised for growth in the coming quarters, courtesy of its continued focus on ...

Sandoz, CIBA-Geigy, Roche and the Basel hub of the pharmaceutical industry all have their roots in this boom. It wasn’t just Swiss companies that had their roots in the dye trade. Bayer was ...

just as key drug, ADHD treatment Adderall XR was facing generic competition. Succeeding him was Flemming Ornskov took on the position of chief executive, joining the company from Bayer ...

A new survey commissioned by One A Day®, the multivitamin and supplement brand by Bayer rooted in more than 80 years of nutritional science, suggests ...

Everything touching artificial intelligence (AI) is hot right now, so it's no surprise that the biotech Recursion ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

The U.S. government has awarded Moderna $590 million to advance the late-stage development of its mRNA bird flu vaccine, as ...

Scientists have made 'exciting,' patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds ...

Los Angeles Assistand Fire Chief Joe Everett said he felt like he "failed" the Palisades community during a community meeting ...

A story going around claims a restaurant is expressing its displeasure with putting pineapple on pizza by charging more than ...